Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Cost-effectiveness of Screening BRCA1/2 Mutation Carriers With Breast Magnetic Resonance Imaging
260
Zitationen
7
Autoren
2006
Jahr
Abstract
Breast MRI screening is more cost-effective for BRCA1 than BRCA2 mutation carriers. The cost-effectiveness of adding MRI to mammography varies greatly by age.
Ähnliche Arbeiten
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
2015 · 31.464 Zit.
International System for Human Cytogenetic Nomenclature
2020 · 6.882 Zit.
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 · 6.733 Zit.
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene <i>BRCA1</i>
1994 · 6.084 Zit.
AJCC Cancer Staging Manual
2010 · 6.055 Zit.